Artelo Biosciences ARTL
NASDAQ ARTL
$2.55 +0.00 (+0.00%)
At close: Oct 23, 2026 · 4:00 PM EDT

Artelo Biosciences (ARTL) Gains from Investment Securities (2021 - 2025)

Updated

Analysis

Artelo Biosciences (ARTL) Gains from Investment Securities (2021 - 2025) Analysis & Trends

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,199.50 Bn 1,168.08 Bn 19.71 Bn
2 Johnson & Johnson 635.17 Bn 555.03 Bn 17.30 Bn
3 AbbVie 504.69 Bn 477.85 Bn 12.70 Bn
4 Merck 358.43 Bn 312.86 Bn 12.21 Bn
5 Novartis Ag 288.36 Bn 252.75 Bn 11.24 Bn
6 Astrazeneca 265.78 Bn 239.54 Bn 12.86 Bn
7 Amgen 237.46 Bn 192.86 Bn 7.24 Bn
8 Gilead Sciences 193.65 Bn 167.76 Bn 6.22 Bn
9 Pfizer 171.05 Bn 118.00 Bn 10.94 Bn
10 Artelo Biosciences 50,806.20 -5.08 Mn -
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2025 75,000.00
Mar 31, 2024 106,000.00
Dec 31, 2023 167,000.00
Sep 30, 2023 165,000.00
Jun 30, 2023 185,000.00
Mar 31, 2023 124,000.00
Dec 31, 2022 137,000.00
Sep 30, 2022 69,000.00
Jun 30, 2022 -21,000.00
Mar 31, 2022 20,000.00
Nov 30, 2021 3,000.00
Feb 28, 2021 -1,335.00
API Access

Artelo Biosciences Gains from Investment Securities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gains-from-investment-securities&ticker=ARTL&period=max&api_key=YOUR_API_KEY